In addition to the STAT pathways, PI3K/AKT and MAPK/ERK signalling pathways were also downstream of BCR-ABL signalling and may contribute to the transformation of CML cells[7]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.